ILMN stock news · Illumina, Inc.
Get alerts for ILMN
Follow Illumina, Inc. (ILMN) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ILMNARK Invest has bought more shares of Pacific Biosciences and other biotech companies.
NeutralIllumina was named among the companies ARK added to its holdings. The report gives no new company results or plans, so its business outlook is unchanged.
Illumina shared its third-quarter 2026 earnings, expecting to make between $4.64 billion and $4.66 billion this year.
Good for ILMNIllumina's sales grew, and it raised its full-year sales and adjusted profit-per-share forecasts. The update points to a stronger business outlook.
Illumina will stream a chat at the UBS Global Healthcare Conference on November 10, 2026.
NeutralIllumina’s managers are scheduled to speak at a healthcare conference, but the notice reports no business change, so it does not shift the company’s outlook.
Illumina, Inc. has signed an important deal to start a program that lets them borrow up to $1 billion.
NeutralIllumina set up a short-term borrowing program of up to $1.0 billion, but had borrowed nothing by the filing date. The report does not change its outlook today.
On Wednesday, LuxExperience, Alvotech, Twist Bioscience, and other major stocks saw big price jumps.
NeutralThe share gain is noted, but no company-specific news in the story changes how we read Illumina.